NantKwest Profile

5.22
USD 0.17  3.37%
4.83Last Month High 5.22 
5.04Trading Day  High 5.22 

Sale by Gorlin Steve of 604 shares of NantKwest

NantKwest Inc insider trading alert for sale of common stock by Gorlin Steve, the corporate stakeholder, on November 13, 2017. This event was filed by Nantkwest Inc with SEC on 2017-09-13. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

NantKwest Summary

NantKwest Inc (NK) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 73 people. NantKwest is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with market capitalization of 394.1 M. NantKwest Inc is active under Healthcare sector as part of Biotechnology industry. This company has 79.46 M outstanding shares of which 4.75 M shares are now sold short in the market by investors with about 13.0 days to cover all shorted shares. NK reports about 152.27 M in cash with (45.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.21.
Check NantKwest Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected NantKwest Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

NantKwest Against Markets

Risk Adjusted
Performance Score (0 to 100)
26 
Chance of
< 3% 
NantKwest, Inc., a biotechnology company, engages in developing immunotherapeutic agents for various clinical conditions in the United States. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameNantKwest Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationCALIFORNIA, U.S.A
Business Address3530 John Hopkins Court, San Diego, CA 92121, United States
ExchangeNASDAQ
CIK Number01326110.0
CUSIP63016Q102
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.nantkwest.com
Contact Number858 633 0300
CurrencyUSD - US Dollar

Recommendations

NantKwest Analyst Recommendations
Target PriceAdvice# of Analysts
19.0Buy4Odds
NantKwest Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
NantKwest Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

NantKwest Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.45March 29, 2017
NantKwest Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate